Description

▪ Introduction
Tri Tren 150 by Pharma Nevis is a high-potency injectable anabolic compound formulated with a three-ester blend of Trenbolone, delivering 150 mg/mL for sustained clinical application. Each milliliter contains:

• Trenbolone Acetate – 50 mg (fast-acting)

• Trenbolone Enanthate – 50 mg (mid-duration)

• Trenbolone Hexahydrobenzylcarbonate – 50 mg (long-acting)

This formulation provides a tiered release profile, supporting both rapid and extended anabolic activity. It is intended for therapeutic protocols involving the management of catabolic states, post-surgical recovery, and nutritional deficiency conditions, under licensed medical or research supervision.

Tri Tren 150 is manufactured under GMP-compliant conditions to ensure pharmaceutical-grade quality, batch consistency, and sterility for regulated professional use.

▪ Product Details

• Active Ingredients: Trenbolone Acetate, Trenbolone Enanthate, Trenbolone Hexahydrobenzylcarbonate

• Total Concentration: 150 mg/mL

• Form: Injectable solution (intramuscular)

• Brand: Pharma Nevis

• Package Size: 10 mL multi-dose vial

• Intended Use: Professional medical or research use only

▪ Pharmacokinetics
Each ester contributes to a staggered pharmacological release:

• Acetate: ~1–2 days

• Enanthate: ~5–7 days

• Hexahydrobenzylcarbonate: ~7–10 days

This composite profile enables consistent plasma levels with reduced injection frequency.

▪ Usage Recommendations

• Typical Dosage: As prescribed by a licensed healthcare provider

• Route: Intramuscular injection

• Frequency: 1–2 times per week, as per protocol

▪ Disclaimer
This product is intended strictly for professional medical or research use. It is not approved for individuals under 18, pregnant or breastfeeding women, or for any recreational or non-therapeutic applications. All administration must follow applicable laws, institutional guidelines, and medical protocols.